Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study.

D.K. Armstrong; R. Coleman; A.J. White; A. Bircher; D.G. Gibbon; L. Old; RHM Verheijen; S. Weil; M. Philips; D. Chakrabarti

Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study.

D.K. Armstrong, R. Coleman, A.J. White, A. Bircher, D.G. Gibbon, L. Old, RHM Verheijen, S. Weil, M. Philips, D. Chakrabarti

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 2009
Event	Joint ECCO15-34th ESMO - Berlijn, Germany Duration: 20 Sept 2009 → 24 Sept 2009

Conference

Conference	Joint ECCO15-34th ESMO
Country/Territory	Germany
City	Berlijn
Period	20/09/09 → 24/09/09

Cite this

Armstrong, D. K., Coleman, R., White, A. J., Bircher, A., Gibbon, D. G., Old, L., Verheijen, RHM., Weil, S., Philips, M., & Chakrabarti, D. (2009). Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study.. Abstract from Joint ECCO15-34th ESMO, Berlijn, Germany.

@conference{887531e2ae9d4e338a44e6551d904375,

title = "Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study.",

author = "D.K. Armstrong and R. Coleman and A.J. White and A. Bircher and D.G. Gibbon and L. Old and RHM Verheijen and S. Weil and M. Philips and D. Chakrabarti",

year = "2009",

language = "English",

note = "Joint ECCO15-34th ESMO ; Conference date: 20-09-2009 Through 24-09-2009",

}

Armstrong, DK, Coleman, R, White, AJ, Bircher, A, Gibbon, DG, Old, L, Verheijen, RHM, Weil, S, Philips, M & Chakrabarti, D 2009, 'Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study.', Joint ECCO15-34th ESMO, Berlijn, Germany, 20/09/09 - 24/09/09.

Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study. / Armstrong, D.K.; Coleman, R.; White, A.J. et al.
2009. Abstract from Joint ECCO15-34th ESMO, Berlijn, Germany.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: preliminary data from a phase-2 study.

AU - Armstrong, D.K.

AU - Coleman, R.

AU - White, A.J.

AU - Bircher, A.

AU - Gibbon, D.G.

AU - Old, L.

AU - Verheijen, RHM

AU - Weil, S.

AU - Philips, M.

AU - Chakrabarti, D.

PY - 2009

Y1 - 2009

M3 - Abstract

T2 - Joint ECCO15-34th ESMO

Y2 - 20 September 2009 through 24 September 2009

ER -